Skip to main content
. 2015 Oct 29;10(10):e0141549. doi: 10.1371/journal.pone.0141549

Table 2. Effects of esculentin-2CHa and its analogues on insulin- and LDH-release, membrane potential and intracellular calcium concentration in BRIN-BD11 cells.

Peptide BRIN-BD11 cells (Threshold concentration) Mouse islets (Threshold concentration) LDH release (% of control) Membrane potential (AUC, x 103 RFU) Intracellular Ca2+ (AUC, x 102 RFU)
Control (Glucose 5.6mM) - - 100.0±2.9 3.71±1.05 4.30±0.40
Esculentin-2CHa 0.3nM 10nM 102.7±1.1 8.01±0.28** 6.44±0.47*
[L21K]Esculentin-2CHa 0.01nM 10nM 100.6±2.0 7.78±0.31** 6.14±0.41*
[L24K]Esculentin-2CHa 0.01nM 10nM 101.3±3.1 7.87±0.19** 6.28±0.62*
[L28K]Esculentin-2CHa 0.01nM 1nM 101.8±1.5 7.78±0.22** 7.28±0.94*
[C31K]Esculentin-2CHa 0.01nM 0.1nM 100.2±2.8 7.92±0.14** 6.32±0.72*
[C31S, C37S]Esculentin-2CHa 0.01nM 1nM 104.3±3.1 7.96±0.24** 6.55±0.36*
[D20K, D27K]Esculentin-2CHa 0.1nM 10nM 102.5±2.6 7.85±0.32** 6.10±0.46*

LDH release data were obtained at the highest peptide concentration (3 μM). Membrane potential and intracellular Ca2+ experiments were carried out at 1μM concentration. Values are mean ± SEM with n = 8.

*P < 0.05

**P < 0.01 compared with 5.6mM glucose.